LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform
LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.
Machine Learning | 23/05/2024 | By Aishwarya | 170
AI and ML devices transforming healthcare
AI and ML in medical devices transform healthcare aiding diagnosis accuracy: Koji Wada
Machine Learning | 19/04/2022 | By Sudeep Soparkar | 408
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy